Registry of Patients Treated With Systemic Mold-Active Triazoles

CompletedOBSERVATIONAL
Enrollment

2,015

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

April 24, 2020

Study Completion Date

April 24, 2020

Conditions
Invasive Fungal Infection
Interventions
DRUG

Isavuconazonium sulfate

Oral and Intravenous

DRUG

Voriconazole

Oral and Intravenous

DRUG

Posaconazole

Oral and intravenous

Trial Locations (56)

10065

Memorial Sloan Kettering Cancer Center, New York

Weill Cornell Medicine of Cornell University and New York Presbyterian Hospital, New York

14263

Roswell Park Cancer Center, Buffalo

15261

University of Pittsburgh, Pittsburgh

19102

Drexel University College of Medicine, Philadelphia

19104

University of Pennsylvania, Philadelphia

23298

Virginia Commonwealth University, Richmond

26506

WVU Medicine, Morgantown

27157

Wake Forest Baptist Health, Winston-Salem

27710

Duke University, Durham

30322

Emory University, Atlanta

30912

Augusta University, Augusta

35294

University of Alabama - Birmingham, Birmingham

38105

St. Jude Childrens Research Hospital, Memphis

40207

Norton Cancer Institute, Louisville

40536

University of Kentucky, Lexington

44106

Case Western Reserve University, Cleveland

45801

Regional Infectious Disease and Infusion Center, Inc., Lima

46202

Indiana University Health, Indianapolis

48109

University of Michigan Cancer Center, Ann Arbor

48201

Wayne State University, Detroit

48202

Henry Ford Hospital, Detroit

55455

University of Minnesota, Minneapolis

55905

Mayo Clinic, Rochester

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Northwestern University, Chicago

60612

University of Illinois at Chicago, Chicago

60637

University of Chicago, Chicago

60660

Loyola University, Chicago

62703

Springfield Clinic, Springfield

63110

Washington University St. Louis, St Louis

64108

Children's Mercy Hospital, Kansas City

66160

University of Kansas Medical Center, Kansas City

68198

University of Nebraska Medical Center, Omaha

70112

Tulane Medical Center, New Orleans

70121

Ochsner Clinic Foundation, New Orleans

77030

University of Texas Health Science Center, Houston

80045

University of Colorado, Aurora

85013

St. Joseph's Hospital, Phoenix

85054

Mayo Clinic, Phoenix

85724

University of Arizona, Tucson

90095

David Geffen School of Medicine, Los Angeles

90502

LA BioMed, Torrance

91342

Olive View UCLA Medical Center, Sylmar

94305

Stanford Health Care, Palo Alto

95616

University of California, Davis

97239

Oregon Health and Science University, Portland

97330

Good Samaritan Hospital, Corvallis

98104

Swedish Health System, Seattle

98195

University of Washington Medical Center, Seattle

06520

Yale School of Medicine, New Haven

02115

Brigham and Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

08103

Cooper University Hospital, Camden

08876

Robert Wood Johnson University Hospital Somerset, Somerville

02912

Rhode Island Hospital, Providence

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT03066011 - Registry of Patients Treated With Systemic Mold-Active Triazoles | Biotech Hunter | Biotech Hunter